ASAP1 and ovarian cancer: Studies have shown that ASAP1 is associated with tumor development and malignant metastasis in prostate cancer, hepatocellular carcinoma [37], breast cancer [38], head and neck squamous cell carcinomas [39], prostate cancer [40, 41], colorectal cancer [26], and ovarian cancer [25, 42].